COLO-DETECT is a randomised control trial that will evaluate whether colonoscopy assisted with the GI Genius™ Intelligent Endoscopy Module improves the detection of abnormalities such as polyps and cancer compared to standard colonoscopy.
The GI Genius™ Intelligent Endoscopy Module (Medtronic Ltd.) is an artificial intelligence technology platform designed to assist the colonoscopist in the detection of abnormalities within the colon. The GI Genius™ connects to existing endoscopy systems and analyses real time images from the colonoscope camera live feed using artificial intelligence. The technology then highlights areas (with a green box) to the colonoscopist that would benefit from a more detailed inspection.
The study is being undertaken in Bowel Cancer Screening Programme, surveillance, and symptomatic patient populations across 11 sites.
Participants are randomised to receive either GI Genius™ assisted colonoscopy or standard colonoscopy. The results of the colonoscopies are recorded and will be analysed to evaluate the effect of the GI Genius™ in the detection of abnormalities such as polyps and cancers.
This study is led by Newcastle University and South Tyneside and Sunderland NHS Foundation Trust working with North Wales Organisation for Randomised Trials in Health Clinical Trials Unit.
- Professor Colin Rees
- Professor Linda Sharp
- Dr Laura Neilson
- Dr Tom Lee
- Miss Rachel Evans
- Dr Andrew Brand
- Mr Alexander Seager
- Dr James Hampton
- South Tyneside and Sunderland NHS Foundation Trust
- Medtronic
- South Tyneside and Sunderland NHS Foundation Trust
- Kettering General Hospital NHS Foundation Trust
- Bolton NHS Foundation Trust
- North Tees and Hartlepool NHS Foundation Trust
- The Royal Wolverhampton NHS Trust
- South Tees Hospitals NHS Foundation Trust
- Northumbria Healthcare NHS Foundation Trust
- University Hospitals of Morecambe Bay NHS Foundation Trust
- Newcastle Hospitals NHS Foundation Trust
- Gloucestershire Hospitals NHS Foundation Trust
- University Hospitals Sussex NHS Foundation Trust
COLO-DETECT trial manager, Dr Alexander Seager, presented COLO-DETECT research at the United European Gastroenterology UEG Week 2023in Copenhagen. This prominent event, which took place from 14-17...
Dr Alexander Seager, Gastrointestinal Research Fellow at South Tyneside and Sunderland NHS Foundation Trust, has been invited to speak about the COLO-DETECT trial at Intelligent...
The COLO-DETECT trial, which closed to recruitment in March, has been in the spotlight! A number of local and UK-wide news organisations, including BBC North,...
We are very pleased to announce that we have completed recruitment to the COLO-DETECT trial. This is a brilliant achievement and we are very grateful...
In support of Colorectal Cancer Awareness Month, COLO-SPEED Chief Investigator, Prof. Colin Rees, and Lead Research Nurse, Ingrid Emmerson, have been featured on episode 9...
We are delighted to announce that COLO-DETECT has now passed its second major milestone of recruiting 1000 patients into the trial and is now halfway...
The COLO-DETECT protocol paper has been published in Colorectal Disease. The paper is available to view online. For more on COLO-DETECT, please view the study...
We are very pleased to report that COLO-DETECT recently passed its first major milestone of recruiting 500 patients into the study! Since recruitment commenced in...
Mr Alexander Seager (Colorectal Surgical Trainee) has joined South Tyneside and Sunderland NHS Foundation Trust as a clinical research fellow to help deliver the COLO-DETECT...
For any other queries about COLO-DETECT please contact [email protected]
